ArticleAging2020

Neuropeptide Y1 receptor antagonist promotes osteoporosis and microdamage repair and enhances osteogenic differentiation of bone marrow stem cells via cAMP/PKA/CREB pathway.

Weixin Xie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.